Skip to main content
Intended for UK Healthcare Professionals. This website contains promotional content.
Intended for IE Healthcare Professionals. This website contains promotional content.
Report adverse events

Prescribing information, details of adverse event reporting and indications can be found at the bottom of this page.

You may also like to visit


Footnotes:

*EASL defines cure as SVR, i.e. undetectable HCV RNA after treatment completion.

†Analysis of DDI risk in patients prescribed DAAs in 2018. Data were collected from a proprietary US EMR database covering 21 healthcare organisations and 26 million patients.7 

Please refer to the SmPC to check for interactions before prescribing.

Abbreviations:

AE = adverse event; DAA = direct-acting antiviral; DDI = drug-drug interaction; EASL = European Association for Study of the Liver; GT = genotype; HCV = hepatitis C virus; IFN = interferon; OST = opioid substitution therapy; RBV = ribavirin; RNA = ribonucleic acid; SVR = sustained virologic response.

UKI-EPC-0075

Date of preparation August 2025